News
SHOPPING: Give your weight loss efforts a serious push with Hims, the weight loss program that is tailored to your unique ...
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...
3d
Zacks Investment Research on MSNHims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...
“The benefits people report most often are way more energy, better workouts and faster recovery, higher libido, clearer ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...
Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss ...
StockStory.org on MSN6d
Why Is Hims & Hers Health (HIMS) Stock Soaring TodayWhat Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the ...
Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results